Dott.ssa Martina Migliorero
- FISIOPATOLOGIA MEDICA
- Dottorato: 36° ciclo
- Dipartimento di Scienze Mediche
- Matricola: 817894
Contatti
- martina.migliorero@unito.it
- Immunogenetics Unit
Department of Medical Sciences
University of Turin
Via Nizza 52, 10126 Torino - https://dott-fisiopatologia.campusnet.unito.it/do/studenti.pl/Show?817894
- VCard contatti
- QRcode contatti
Supervisore
Benedetta BussolatiAttività di ricerca
Functional validation of a newly discovered pathogenic variant in a child affected by 3MC syndrome
Functional validation of Variants of Unknown Significance (VUS) identified trough clinical exome sequencing in a cohort of patients suffering from Polycystic Kidney Disease (PKD)
Transcriptional characterization of cystic cells obtained from ADPKD patients through single-nuclei RNA sequencing.
Migliorero M. et al. “A novel COLEC10 mutation in a child with 3MC syndrome” European Journal of Medical Genetics, 2021.
Chiotto A. M., Migliorero M. “Neuronal Cell-Intrinsic Defects in Mouse Models of Down Syndrome” Frontiers in Neuroscience, 2019
Migliorero M. et al. COLEC10 and 3MC syndrome: expanding the genotypic and phenotypic spectrum of a very rare disease. 22nd-23rd February 2021, Rare2021, eposter.
Migliorero M. et al. COLEC10 and 3MC syndrome: expanding the genotypic and phenotypic spectrum of a very rare disease. 5th-8th June 2021, 58th ERA-EDTA virtual congress, mini-oral.
Migliorero M. et al. COLEC10 and 3MC syndrome: expanding the genotypic and phenotypic spectrum of a very rare disease. 28th-31th August 2021 – European Society of Human Genetics (ESHG), eposter presentation
Migliorero M, Bracciamà V, Arruga F, Vitale N, Sorbini M, Amoroso A, Vaisitti T, Deaglio S (2022). Development of a new cellular model to understand genotype-phenotype correlations in patients with polycystic kidney disease exploiting CRISPR/Cas9 system.
Migliorero M, Bracciamà V, Arruga F, Amoroso A, Vaisitti T, Deaglio S (2022). Development of a cellular tool based on CRISPR/Cas9 system to study genotype-phenotype correlations for Polycystic Kidney Disease patients.
Saglia C, Kalantari S, Albanese S, Tessaris D., Carli D, Migliorero M, Arruga F, Amoroso A, De Sanctis L, Vaisitti T, Deaglio S (2023). Functional evaluation of a novel nonsense variant of the CASR gene identified in a patient with chronic hypocalcemia.
Migliorero M, Marsalla D, Saglia C, Bracciamà V, Arruga F, Amoroso A, Vaisitti T, Deaglio S (2023). Development of a new cellular model to evaluate the clinical impact of PKD1 variants exploiting base editors.
Migliorero M, Marsalla D, Saglia C, Bracciamà V, Arruga F, Amoroso A, Vaisitti T, Deaglio S (2023). Development of a new cellular model to evaluate the clinical impact of PKD1 variants exploiting CRISPR/Cas9 system
22nd-23rd February 2021, Virtual congress of rare disorders (Rare2021), eposter presentation.
5th-8th June 2021, ERA-EDTA virtual congress, mini-oral presentation.
28th-31st August 2021 – European Society of Human Genetics (ESHG) virtual congress, mini-oral
June 2022 - European Society of Human Genetics (ESHG), mini-oral presentation, Vienna
September 2022 - Società Italiana di Genetica Umana (SIGU), mini-oral presentation, Trieste
June 2023 - European Society of Human Genetics (ESHG), poster, Glasgow
June 2023 - European Renal Association (ERA), mini-oral presentation - Milan. Best poster for young authors
May 2023. Regulation of Cellular Homeostasis through Mitochondrial-Nuclear Communication, Dr. Valentina Perissi
June 2023. Identification of a novel phosphoinositide-lysosomal signalling axis and its roles in cancer progression and therapy resistance. Dr. Leonardo Salmena
July 2023. Cellular metabolism environment and neocortical growth: new pathways underlying microcephaly pathogenesis? Dr. Pierre Gressens
October 2023. Mechanisms of Somatic Mutation and Tumor Initiation in the Aging Kidney, Dr Irene Franco
December 2022. Myotubularin-related protein (MTMR) phosphoinositide phosphatases and inherited neuropathies, Dr. Alessandra Bolino
December 2022. Functional imaging of nanodomains in cardiomyocytes, Dr. Julia Gorelik
November 2022. Biomedical nanofluidics for controlled cell and drug delivery, Dr. Alessandro Grattoni
October 2022. Small GTPase Rap1 signaling in endothelium, Dr. Magdalena Chrzanowska
June 2022. Systems Immunology of human disease through multiomics integration, Dr. Francesco Vallania
June 2021. Gene And Cell Therapy of Duchenne Muscular Dystrophy, Dr. Giulio Cossu UNITO
April 2021. Structural Variation in Disease And Evolution, Giuliana Giannuzzi UNITO
March 2021. Phenotype-Driven Variant Prioritization Tool for Rare Disease Molecular Diagnosis and Gene Discovery – Using Exomiser at Scale in the Uk 100,000 Genomes Project, Dr. Valentina Cipriani UNITO
February 2021. Genome-Wide Risk and its Application to Prevention in Complex Diseases, Prof. Samuli Ripatti UNITO
January 2021. Diagnosi Genetica Preimpianto - Pgt: Applicazioni E Limiti. Dr. Daniela Zuccarello. UNITO
December 2020. Roadmap to genome interpretation, from variant-effect prediction to the in-silico diagnosis of genetic disorders. Dr. Daniele Raimondi UNITO
December 2020. Understanding human pluripotency by X chromosome reactivation. Dr. Irene Cantone. Federico II University, Naples.
December 2020. Synergistic efficacy of dual PI3K-g/d inhibitor Duvelisib with Bcl-2 inhibitor Venetoclax in Richter’s Syndrome PDX models. Dr. Andrea Iannello. UNITO
November 2020. Immune escape mechanisms in chronic lymphocytic leukemia. Dr. Martina Seiffert. German Cancer Research Center (DKFZ), Heidelberg
Corso di formazione in materia di Igiene e Sicurezza - Rischio Alto in area sanitaria - Settore Ateco 2007 Q 86 - (D. Lgs. 81/08 s.m.i.)
Lectures provided by the doctoral school of medical physiopathology - University of Turin (2021)
Lectures provided by the doctoral school of medical physiopathology - University of Turin (2022)
Lectures provided by the doctoral school of medical physiopathology - University of Turin (2023)
ZEBRAFISH COME ORGANISMO MODELLO: APPROCCI SPERIMENTALI IN VITRO E IN VIVO NELLA RICERCA SCIENTIFICA - Istituto Zooprofilattico Sperimentale
della Lombardia e dell’Emilia Romagna
BIOLOGIA E GESTIONE DEGLI ANIMALI DA LABORATORIO, MODULI 3.1, 4, 5, 6.1, 7. DM 5 AGOSTO 2021 RODITORI E LAGOMORFI - Istituto Zooprofilattico Sperimentale
della Lombardia e dell’Emilia Romagna
LEGISLAZIONE NAZIONALE ED ETICA LIVELLO 1, MODULI 1 E 2, DM 5 AGOSTO 2021 - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna
ETICA E CONCEZIONE DEI PROGETTI, MODULI 9, 10, 11, DM 5 AGOSTO 2021 - Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna